IDEAYA Biosciences, Inc.IDYAEarnings & Financial Report
Nasdaq
IDYA Q3 2025 Key Financial Metrics
Revenue
$207.8M
Gross Profit
N/A
Operating Profit
$108.5M
Net Profit
$119.2M
Gross Margin
N/A
Operating Margin
52.2%
Net Margin
57.4%
YoY Growth
N/A
EPS
$1.33
Financial Flow
IDEAYA Biosciences, Inc. Q3 2025 Financial Summary
IDEAYA Biosciences, Inc. reported revenue of $207.8M for Q3 2025, with a net profit of $119.2M (57.4% margin). Cost of goods sold was N/A, operating expenses totaled N/A.
Key Financial Metrics
| Total Revenue | $207.8M |
|---|---|
| Net Profit | $119.2M |
| Gross Margin | N/A |
| Operating Margin | 52.2% |
| Report Period | Q3 2025 |
IDEAYA Biosciences, Inc. Annual Revenue by Year
IDEAYA Biosciences, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $7.0M).
| Year | Annual Revenue |
|---|---|
| 2024 | $7.0M |
| 2023 | $23.4M |
| 2022 | $50.9M |
Income Statement
| Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $3.5M | $8.0M | $3.9M | $0 | $0 | $0 | $7.0M | $207.8M |
| YoY Growth | -39.4% | -72.9% | -2.5% | N/A | N/A | N/A | 78.4% | N/A |
Balance Sheet
| Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $527.6M | $532.9M | $649.3M | $961.5M | $973.7M | $1.24B | $1.12B | $1.19B |
| Liabilities | $25.9M | $24.9M | $28.2M | $26.2M | $42.0M | $59.5M | $64.9M | $93.1M |
| Equity | $501.6M | $508.0M | $621.1M | $935.3M | $931.7M | $1.18B | $1.06B | $1.09B |
Cash Flow
| Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q3 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-33.5M | $-30.2M | $-23.7M | $-43.8M | $-32.9M | $-49.2M | $-121.7M | $142.2M |